Findings from a feasibility study of estradiol for hypogonadal women with cystic fibrosis-related bone disease

BACKGROUND: Advancements in therapies for patients with cystic fibrosis (CF) have decreased mortality, leading to increased prevalence of chronic complications including bone disease. CF-related bone disease (CFBD) is characterized by low bone mineral density (BMD) and fragility fractures. Estrogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Malinda, Tirouvanziam, Rabindra, Arora, Neha, Tangpricha, Vin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375209/
https://www.ncbi.nlm.nih.gov/pubmed/34412687
http://dx.doi.org/10.1186/s40814-021-00897-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375209/
https://www.ncbi.nlm.nih.gov/pubmed/34412687
http://dx.doi.org/10.1186/s40814-021-00897-x

Ejemplares similares